Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma

Frédéric A. Van Den Brûle, Crina Buicu, Andy Berchuck, Robert C. Bast, Manuel Deprez, Fu-Tong Liu, Douglas N W Cooper, Claudette Pieters, Mark E. Sobel, Vincent Castronovo

Research output: Contribution to journalArticle

136 Citations (Scopus)

Abstract

Alterations of tumor cell interactions with laminin, a basement membrane glycoprotein, are consistent features of the invasive and metastatic phenotype. Qualitative and quantitative changes in the expression of cell surface laminin-binding proteins have been correlated with the ability of cancer cells to cross basement membranes during the metastatic cascade. Such phenotypic modifications are usually associated with poor prognosis. In this study, the authors examined the possibility that expression of three laminin- binding proteins, the 67-kD laminin receptor (67LR), galectin-l, and galectin-3, is altered in human endometrial cancer in a fashion similar to that reported in other carcinomas, such as breast, colon, and ovarian cancer. Twenty advanced uterine adenocarcinomas were analyzed for expression of these three molecules using immunoperoxidase staining and specific antibodies. The authors found a significant increase in the expression of the 67LR and galectin-1 in cancer cells compared with normal adjacent endometrium (P = .0004 and .0022, respectively). As observed in other carcinomas, a significant down-regulation of galectin-3 expression was found in endometrial cancer cells compared with normal mucosa (P = .02). In the galectin-3 positive tumors, galectin-3 was detected in the cytoplasm and/or nucleus of cancer cells. Interestingly, tumors in which galectin-3 was detected only in the cytoplasm were characterized by deeper invasion of the myometrium than lesions where galectin-3 was found both in nucleus and cytoplasm (P = .02). This study shows an alteration of nonintegrin laminin-binding protein expression in advanced human endometrial cancer. Further studies on larger populations should determine the prognostic value of the detection of these laminin-binding proteins in endometrial carcinoma. Inverse modulation of the 67LR and galectin-3 appears to be a phenotypical feature of invasive carcinoma.

Original languageEnglish (US)
Pages (from-to)1185-1191
Number of pages7
JournalHuman Pathology
Volume27
Issue number11
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Galectin 1
Laminin Receptors
Galectin 3
Adenocarcinoma
Laminin
Endometrial Neoplasms
Carrier Proteins
Neoplasms
Cytoplasm
Carcinoma
Basement Membrane
Galectins
Myometrium
Membrane Glycoproteins
Endometrium
Cell Nucleus
Cell Communication
Ovarian Neoplasms
Colonic Neoplasms
Mucous Membrane

Keywords

  • expression
  • galectins
  • invasion
  • laminin-binding proteins
  • uterine adenocarcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Van Den Brûle, F. A., Buicu, C., Berchuck, A., Bast, R. C., Deprez, M., Liu, F-T., ... Castronovo, V. (1996). Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma. Human Pathology, 27(11), 1185-1191. https://doi.org/10.1016/S0046-8177(96)90313-5

Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma. / Van Den Brûle, Frédéric A.; Buicu, Crina; Berchuck, Andy; Bast, Robert C.; Deprez, Manuel; Liu, Fu-Tong; Cooper, Douglas N W; Pieters, Claudette; Sobel, Mark E.; Castronovo, Vincent.

In: Human Pathology, Vol. 27, No. 11, 1996, p. 1185-1191.

Research output: Contribution to journalArticle

Van Den Brûle, FA, Buicu, C, Berchuck, A, Bast, RC, Deprez, M, Liu, F-T, Cooper, DNW, Pieters, C, Sobel, ME & Castronovo, V 1996, 'Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma', Human Pathology, vol. 27, no. 11, pp. 1185-1191. https://doi.org/10.1016/S0046-8177(96)90313-5
Van Den Brûle, Frédéric A. ; Buicu, Crina ; Berchuck, Andy ; Bast, Robert C. ; Deprez, Manuel ; Liu, Fu-Tong ; Cooper, Douglas N W ; Pieters, Claudette ; Sobel, Mark E. ; Castronovo, Vincent. / Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma. In: Human Pathology. 1996 ; Vol. 27, No. 11. pp. 1185-1191.
@article{35d299f831db4b848230eb0ab6c3d81b,
title = "Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma",
abstract = "Alterations of tumor cell interactions with laminin, a basement membrane glycoprotein, are consistent features of the invasive and metastatic phenotype. Qualitative and quantitative changes in the expression of cell surface laminin-binding proteins have been correlated with the ability of cancer cells to cross basement membranes during the metastatic cascade. Such phenotypic modifications are usually associated with poor prognosis. In this study, the authors examined the possibility that expression of three laminin- binding proteins, the 67-kD laminin receptor (67LR), galectin-l, and galectin-3, is altered in human endometrial cancer in a fashion similar to that reported in other carcinomas, such as breast, colon, and ovarian cancer. Twenty advanced uterine adenocarcinomas were analyzed for expression of these three molecules using immunoperoxidase staining and specific antibodies. The authors found a significant increase in the expression of the 67LR and galectin-1 in cancer cells compared with normal adjacent endometrium (P = .0004 and .0022, respectively). As observed in other carcinomas, a significant down-regulation of galectin-3 expression was found in endometrial cancer cells compared with normal mucosa (P = .02). In the galectin-3 positive tumors, galectin-3 was detected in the cytoplasm and/or nucleus of cancer cells. Interestingly, tumors in which galectin-3 was detected only in the cytoplasm were characterized by deeper invasion of the myometrium than lesions where galectin-3 was found both in nucleus and cytoplasm (P = .02). This study shows an alteration of nonintegrin laminin-binding protein expression in advanced human endometrial cancer. Further studies on larger populations should determine the prognostic value of the detection of these laminin-binding proteins in endometrial carcinoma. Inverse modulation of the 67LR and galectin-3 appears to be a phenotypical feature of invasive carcinoma.",
keywords = "expression, galectins, invasion, laminin-binding proteins, uterine adenocarcinoma",
author = "{Van Den Br{\^u}le}, {Fr{\'e}d{\'e}ric A.} and Crina Buicu and Andy Berchuck and Bast, {Robert C.} and Manuel Deprez and Fu-Tong Liu and Cooper, {Douglas N W} and Claudette Pieters and Sobel, {Mark E.} and Vincent Castronovo",
year = "1996",
doi = "10.1016/S0046-8177(96)90313-5",
language = "English (US)",
volume = "27",
pages = "1185--1191",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma

AU - Van Den Brûle, Frédéric A.

AU - Buicu, Crina

AU - Berchuck, Andy

AU - Bast, Robert C.

AU - Deprez, Manuel

AU - Liu, Fu-Tong

AU - Cooper, Douglas N W

AU - Pieters, Claudette

AU - Sobel, Mark E.

AU - Castronovo, Vincent

PY - 1996

Y1 - 1996

N2 - Alterations of tumor cell interactions with laminin, a basement membrane glycoprotein, are consistent features of the invasive and metastatic phenotype. Qualitative and quantitative changes in the expression of cell surface laminin-binding proteins have been correlated with the ability of cancer cells to cross basement membranes during the metastatic cascade. Such phenotypic modifications are usually associated with poor prognosis. In this study, the authors examined the possibility that expression of three laminin- binding proteins, the 67-kD laminin receptor (67LR), galectin-l, and galectin-3, is altered in human endometrial cancer in a fashion similar to that reported in other carcinomas, such as breast, colon, and ovarian cancer. Twenty advanced uterine adenocarcinomas were analyzed for expression of these three molecules using immunoperoxidase staining and specific antibodies. The authors found a significant increase in the expression of the 67LR and galectin-1 in cancer cells compared with normal adjacent endometrium (P = .0004 and .0022, respectively). As observed in other carcinomas, a significant down-regulation of galectin-3 expression was found in endometrial cancer cells compared with normal mucosa (P = .02). In the galectin-3 positive tumors, galectin-3 was detected in the cytoplasm and/or nucleus of cancer cells. Interestingly, tumors in which galectin-3 was detected only in the cytoplasm were characterized by deeper invasion of the myometrium than lesions where galectin-3 was found both in nucleus and cytoplasm (P = .02). This study shows an alteration of nonintegrin laminin-binding protein expression in advanced human endometrial cancer. Further studies on larger populations should determine the prognostic value of the detection of these laminin-binding proteins in endometrial carcinoma. Inverse modulation of the 67LR and galectin-3 appears to be a phenotypical feature of invasive carcinoma.

AB - Alterations of tumor cell interactions with laminin, a basement membrane glycoprotein, are consistent features of the invasive and metastatic phenotype. Qualitative and quantitative changes in the expression of cell surface laminin-binding proteins have been correlated with the ability of cancer cells to cross basement membranes during the metastatic cascade. Such phenotypic modifications are usually associated with poor prognosis. In this study, the authors examined the possibility that expression of three laminin- binding proteins, the 67-kD laminin receptor (67LR), galectin-l, and galectin-3, is altered in human endometrial cancer in a fashion similar to that reported in other carcinomas, such as breast, colon, and ovarian cancer. Twenty advanced uterine adenocarcinomas were analyzed for expression of these three molecules using immunoperoxidase staining and specific antibodies. The authors found a significant increase in the expression of the 67LR and galectin-1 in cancer cells compared with normal adjacent endometrium (P = .0004 and .0022, respectively). As observed in other carcinomas, a significant down-regulation of galectin-3 expression was found in endometrial cancer cells compared with normal mucosa (P = .02). In the galectin-3 positive tumors, galectin-3 was detected in the cytoplasm and/or nucleus of cancer cells. Interestingly, tumors in which galectin-3 was detected only in the cytoplasm were characterized by deeper invasion of the myometrium than lesions where galectin-3 was found both in nucleus and cytoplasm (P = .02). This study shows an alteration of nonintegrin laminin-binding protein expression in advanced human endometrial cancer. Further studies on larger populations should determine the prognostic value of the detection of these laminin-binding proteins in endometrial carcinoma. Inverse modulation of the 67LR and galectin-3 appears to be a phenotypical feature of invasive carcinoma.

KW - expression

KW - galectins

KW - invasion

KW - laminin-binding proteins

KW - uterine adenocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=0242584094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242584094&partnerID=8YFLogxK

U2 - 10.1016/S0046-8177(96)90313-5

DO - 10.1016/S0046-8177(96)90313-5

M3 - Article

VL - 27

SP - 1185

EP - 1191

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 11

ER -